Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Avidity Biosciences, Inc. (RNA) Shares Issued (2019 - 2025)

Avidity Biosciences' Shares Issued history spans 7 years, with the latest figure at -$18.7 million for Q4 2025.

  • For Q4 2025, Shares Issued rose 79.49% year-over-year to -$18.7 million; the TTM value through Sep 2025 reached -$72.3 million, down 151.15%, while the annual FY2024 figure was $50.4 million, 61.63% up from the prior year.
  • Shares Issued reached -$18.7 million in Q4 2025 per RNA's latest filing, down from $18.7 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $519.3 million in Q4 2022 to a low of -$91.0 million in Q4 2024.
  • Average Shares Issued over 5 years is $53.8 million, with a median of $912000.0 recorded in 2021.
  • Peak YoY movement for Shares Issued: surged 224310.0% in 2023, then tumbled 100.4% in 2024.
  • A 5-year view of Shares Issued shows it stood at $1.3 million in 2021, then soared by 39211.13% to $519.3 million in 2022, then plummeted by 92.66% to $38.1 million in 2023, then crashed by 338.76% to -$91.0 million in 2024, then skyrocketed by 79.49% to -$18.7 million in 2025.
  • Per Business Quant, the three most recent readings for RNA's Shares Issued are -$18.7 million (Q4 2025), $18.7 million (Q3 2025), and -$91.0 million (Q4 2024).